Basic immunization against TBE in persons over fifty years with FSME-IMMUN Adults

Basic immunization against TBE in persons over fifty years with FSME-IMMUN Adults - PRIMER

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00003496

Enrollment

600

Registered

2012-01-25

Start date

2012-02-02

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prophylaxis of TBE in adult persons over fifty years A84.1 A84.1

Interventions

Group 1: Each participating site documents once at the start of participation whether and how it motivates patients to have the TBE vaccination. Once the patients consent to disclosure of his or her p

Eligibility

Sex/Gender

All

Age

50 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients 50 years and older who receive the basic immunization with FSME-IMMUN Adults can be considered for the target population. The patients must not have received any TBE vaccination in the past and must not have ever been infected with TBE. They must have given their written consent to participate in this noninterventional study.

Exclusion criteria

Exclusion criteria: no exclusion criteria

Design outcomes

Primary

Measure	Time frame
Identify methods for motivating patients for TBE vaccination in practices: Documentation once per site on a separate questionnaire. Collect patients' motivation and indication for TBE vaccination: Documentation once in the CRF. Identify vaccinations with FSME-IMMUN Adults: Documentation in the CRF. Documentation in the CRF whether the antibody concentration is determined after the 2nd vaccination - If performed: Identify antibody concentration - If performed: Identify whether the antibody measurement leads to administration of an additional vaccine dose. - If yes: Documentation of the additional vaccination	—

Measure

Time frame

Identify methods for motivating patients for TBE vaccination in practices: Documentation once per site on a separate questionnaire. Collect patients' motivation and indication for TBE vaccination: Documentation once in the CRF. Identify vaccinations with FSME-IMMUN Adults: Documentation in the CRF. Documentation in the CRF whether the antibody concentration is determined after the 2nd vaccination - If performed: Identify antibody concentration - If performed: Identify whether the antibody measurement leads to administration of an additional vaccine dose. - If yes: Documentation of the additional vaccination

—

Countries

Germany

Contacts

Public ContactAnja Reichert

Baxter Deutschland GmbH

anja_reichert at baxter.comTel.: 089 31701- 448

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026